Braskem S.A.

NYSE:BAK

Chemicals

Basic Materials
$0.86 -11.76%

-$0.40 today

Market cap
$343.37M
Beta
0.67
P/E (TTM)
-0.7
EPS (TTM)
-$11.45
52W Low $2.32High $5.40

Volume 3.32M

Average 2.97M

BAK Depreciation & Amortization

Non-cash asset write-downs added back to net income because no cash left the business.

Braskem S.A.NYSE: BAK

Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026

Depreciation & amortization declines year over year

Q1 FY2026 depreciation & amortization of R$1.15B fell 3.4% year over year, ahead of the -7.3% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 2.3% from the prior quarter. Over 3 fiscal years it compounded at -1.1% a year.

Context

  • Depreciation & amortization amounted to 6.6% of revenue in FY2025, up 0.2 pp from a year earlier.
  • Depreciation & amortization increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -3.4% holds above the trailing-twelve-month pace of -7.3%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
R$1.15B-2.3% QoQ
Last fiscal yearDec 2025
R$4.58B-7.5% YoY
LTMMar 2026
R$4.65B-7.3% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-3.4%——
1 year-7.5%——
3-year CAGR-1.1%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

BRL · from the cash flow

Latest · FY2025
4.58B BRL
Year-over-year change
-7.5%
4-year CAGR
-1.5%

Depreciation & Amortization vs competitors

How BAK compares with its peers on the latest reported figures

  • Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -7.3% is the 9th highest of 11, against a peer median of +8.5%.
  • Depreciation & amortization amounts to 7.0% of revenue for BAK, versus a peer median of 10.2%.
BAK Competitors
Depreciation & Amortization for BAK and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BAKBraskem S.A.LTM Mar 2026R$4.65B BRL-7.3%-1.1%7.0%
RYAMRayonier Advanced Materials Inc.LTM Mar 2026$135.79M USD+0.5%-0.1%9.5%
WLKPWestlake Chemical Partners LPLTM Mar 2026$135.21M USD+21.8%+1.9%11.0%
SCLStepan CompanyLTM Mar 2026$129.72M USD+13.9%+10.0%5.5%
UANCVR Partners, LPLTM Mar 2026$83.79M USD-3.5%-0.1%13.0%
ECVTEcovyst Inc.LTM Mar 2026$65.17M USD-28.0%-0.2%8.0%
MUXMcEwen Mining Inc.LTM Mar 2026$35.65M USD+16.4%+12.6%15.1%
REXREX American Resources CorporationLTM Apr 2026$16.7M USD-19.9%-10.4%2.5%
ASPIASP Isotopes Inc. Common StockLTM Mar 2026$4.82M USD+831.9%+197.6%17.9%
CNLCollective Mining Ltd.LTM Mar 2026$1.01M USD+120.6%+56.2%—
NAKNorthern Dynasty Minerals Ltd.LTM Mar 2026CA$170.11K CAD+3.1%-12.8%—
Peer median (excluding BAK) —+8.5%+0.9%10.2%

Competitors are the stored peer set for BAK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

BRL
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income13.98B47M(4.58B)(17.73B)(9.69B)
Depreciation & Amortization4.87B4.73B5.21B4.95B4.58B
Deferred Income Tax00000
Stock-Based Compensation14.39M010M00
Change in Working Capital(12.48B)3.97B(3.96B)557M(1.71B)
Accounts Receivables(2.18B)4.65B72M609M321.56M
Inventory(7.57B)2.14B1.81B(181M)2.88B
Accounts Payables0514M0384M(2.3B)
Other Working Capital(2.73B)(3.34B)(5.84B)(255M)(2.61B)
Other Non-Cash Items8.39B203M1.05B14.66B2.72B
Operating Cash Flow14.79B8.95B(2.27B)2.44B(4.09B)
Capital Expenditures(3.42B)(4.85B)(4.53B)(3.76B)(3.07B)
Acquisitions (Net)0(107M)(78M)203M100M
Purchases of Investments0(64.97M)00(77.45M)
Sales of Investments0000105.88M
Other Investing Activities40.65M72.97M83M73M0
Investing Cash Flow(3.38B)(4.95B)(4.53B)(3.49B)(2.94B)
Debt Repayment(10.97B)1.55B8.28B437M3.2B
Common Stock Issued00000
Common Stock Repurchased00000
Dividends Paid(5.99B)(1.35B)(7M)(6M)0
Other Financing Activities021M596M38M(63.8M)
Financing Cash Flow(16.97B)225M8.87B469M3.13B
Effect of Forex Changes377.53M(444M)(355M)1.38B1.1B
Net Change in Cash(5.18B)3.79B1.72B799M(2.79B)
Free Cash Flow11.37B4.1B(6.8B)(1.33B)(7.16B)

Braskem S.A.

NYSE:BAK

Intrinsic Alpha fair value

Locked

Current Price

$0.86

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.